Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris

NCT01773122 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

77

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: Dapsone Formulation A
DRUG: Dapsone Formulation B
DRUG: Dapsone Formulation C
DRUG: Dapsone 5% Gel

Sponsor

Allergan